News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Edwards Lifesciences
(NY:
EW
)
68.92
+0.80 (+1.17%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Edwards Lifesciences
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff
April 25, 2024
The company also raised its outlook for the year and now expects 8% to 10% sales growth.
Via
Investor's Business Daily
Edwards Lifesciences Reports First Quarter Results
April 25, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Decoding Edwards Lifesciences's Options Activity: What's the Big Picture?
April 25, 2024
Via
Benzinga
Behind the Scenes of Edwards Lifesciences's Latest Options Trends
April 18, 2024
Via
Benzinga
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
April 18, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
$1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today
April 12, 2024
Via
Benzinga
How Is The Market Feeling About Edwards Lifesciences?
April 12, 2024
Via
Benzinga
What Analysts Are Saying About Edwards Lifesciences Stock
April 11, 2024
Via
Benzinga
$100 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth This Much Today
April 02, 2024
Via
Benzinga
The 5 Stocks Most Sold By Insiders This Year
April 16, 2024
Insiders are selling these 5 stocks increased as their markets advanced, and gains may be capped. Long-term outlooks are positive for growth and share prices.
Via
MarketBeat
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
April 07, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
The Latest Analyst Ratings For Edwards Lifesciences
March 26, 2024
Via
Benzinga
Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
March 19, 2024
The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81.
Via
Investor's Business Daily
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
March 14, 2024
Via
Benzinga
What 9 Analyst Ratings Have To Say About Edwards Lifesciences
March 07, 2024
Via
Benzinga
Looking Into Edwards Lifesciences's Recent Short Interest
February 27, 2024
Via
Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $3,200 Today
February 12, 2024
Via
Benzinga
Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
March 11, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
February 23, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
February 22, 2024
Via
Benzinga
FDA Advisors Set To Discuss Abbott's TriClip For Heart Valve Disorder As Questions On Pivotal Trial Loom
February 12, 2024
FDA to review Abbott's TriClip G4 System for severe tricuspid regurgitation. Circulatory System Devices Panel meeting and insights from the briefing document.
Via
Benzinga
Exposures
Product Safety
Can financial, healthcare, energy stocks rise as rates stay high?
February 08, 2024
Sectors including financials, healthcare, utilities and energy outperform as interest rates remain high, but some of those industries face challenges in 2024.
Via
MarketBeat
Earnings Scheduled For February 6, 2024
February 06, 2024
Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion.
Via
Benzinga
Edwards Lifesciences Earnings Preview
February 05, 2024
Via
Benzinga
These Analysts Boost Their Forecasts On Edwards Lifesciences Following Q4 Results
February 07, 2024
Edwards Lifesciences Corporation (NYSE: EW) reported in-line earnings for its fourth quarter on Tuesday.
Via
Benzinga
Edwards Lifesciences Dips On In-Line Profit, Narrow Sales Beat
February 06, 2024
The company narrowly topped sales expectations and adjusted profit came in line.
Via
Investor's Business Daily
Edwards Lifesciences Reports Fourth Quarter Results
February 06, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Tech Slides, Chinese Stocks Rebound, New York Community Bancorp Tumbles: What's Driving Markets Tuesday?
February 06, 2024
At noon trading in New York, major equity indices on Wall Street remain directionless as traders evaluate the future course of monetary policy ahead of several speeches by Federal Reserve officials in...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Expert Ratings For Edwards Lifesciences
February 02, 2024
Via
Benzinga
US Stocks Brace For Another Day In The Red As Rally Loses Steam: Analyst Sees Market Pullback On This Indicator
February 06, 2024
The stock rally that propelled the S&P 500 and the Dow to record highs last week seems to have stalled, with Fed officials remaining non-committal about rate-cut plans.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.